BCM Technologies’ investment strategy revolves around the concept that maximum returns from early stage life science investing will result
Business Model:
Revenue: $14.1M
Employees: 2-10
Address: 2 Greenway Plaza
City: Houston
State: TX
Zip: 77046
Country: US
BCM Technologies’ investment strategy revolves around the concept that maximum returns from early stage life science investing will result from impeccable diligence and a solid understanding of the underlying science. BCMT likes to invest early and create substantial value by leveraging the experience of the team to guide the company through the start-up process and avoid common mistakes. Success at such an early stage requires constant rationalization of investments and extreme discipline to focus on the likely winners. BCMT is a true "early-stage investor" that provides seed capital to perform value creating proof-of-concept research and plays a major role in the structuring and development of the start-up company. The initial investment from BCMT is often made for the specific goal of validating the technology through highly focused research activities and initial investment frequently precedes recruitment of a management team. BCMT prefers to lead Seed and First rounds and will continue to co-invest in later rounds.
Contact Phone:
+17137950105
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2006 | Relievant Medsystems | Series B | 0 |
6/2004 | Rejuvenon | Series B | 37M |
1/1999 | Lexicon Pharmaceuticals | Post-IPO Equity | 0 |
10/2006 | Relievant Medsystems | Series B | 0 |
6/2004 | Rejuvenon | Series B | 0 |
1/1999 | Lexicon Pharmaceuticals | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|